Back to search

Article

MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer

2018-02-28

Abstract excerpt

Docetaxel and cabazitaxel are taxane chemotherapy treatments for metastatic castration-resistant prostate cancer (CRPC). However, therapeutic resistance remains a major issue. MicroRNAs are short non-coding RNAs that can silence multiple genes, regulating several signalling pathways simultaneously. Therefore, synthetic microRNAs may have therapeutic potential in CRPC by regulating genes involved in taxane response...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5626054c-8a59-58d1-95b5-82f6193fbe1a
DOI
10.1101/273284
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancerDOI 10.1101/273284
Select a neighboring publication to make it the new centre.